GREEN CROSS WellBeing Corporation - Asset Resilience Ratio
GREEN CROSS WellBeing Corporation (234690) has an Asset Resilience Ratio of 0.63% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read GREEN CROSS WellBeing Corporation (234690) financial obligations for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2016–2024)
This chart shows how GREEN CROSS WellBeing Corporation's Asset Resilience Ratio has changed over time. See GREEN CROSS WellBeing Corporation book value and equity for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down GREEN CROSS WellBeing Corporation's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see GREEN CROSS WellBeing Corporation market cap and net worth.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩0.00 | 0% |
| Short-term Investments | ₩1.43 Billion | 0.63% |
| Total Liquid Assets | ₩1.43 Billion | 0.63% |
Asset Resilience Insights
- Limited Liquidity: GREEN CROSS WellBeing Corporation maintains only 0.63% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
GREEN CROSS WellBeing Corporation Industry Peers by Asset Resilience Ratio
Compare GREEN CROSS WellBeing Corporation's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Fortress Biotech Inc
NASDAQ:FBIO |
Biotechnology | 11.59% |
|
Summit Therapeutics PLC
NASDAQ:SMMT |
Biotechnology | 0.00% |
|
Tubize-Fin
BR:TUB |
Biotechnology | 0.05% |
|
Apellis Pharmaceuticals Inc
NASDAQ:APLS |
Biotechnology | 0.58% |
|
Beijing Tiantan Biological Products Corp Ltd
SHG:600161 |
Biotechnology | 8.08% |
|
BrightGene Bio Medical Technology C
SHG:688166 |
Biotechnology | 1.00% |
|
BioArctic AB (publ)
ST:BIOA-B |
Biotechnology | 72.35% |
|
Chengzhi Shareholding Co Ltd
SHE:000990 |
Biotechnology | 6.73% |
Annual Asset Resilience Ratio for GREEN CROSS WellBeing Corporation (2016–2024)
The table below shows the annual Asset Resilience Ratio data for GREEN CROSS WellBeing Corporation.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 0.89% | ₩1.43 Billion ≈ $970.17K |
₩161.53 Billion ≈ $109.46 Million |
+0.38pp |
| 2023-12-31 | 0.51% | ₩800.00 Million ≈ $542.15K |
₩156.55 Billion ≈ $106.09 Million |
-1.78pp |
| 2022-12-31 | 2.29% | ₩3.45 Billion ≈ $2.34 Million |
₩150.24 Billion ≈ $101.82 Million |
-4.02pp |
| 2021-12-31 | 6.31% | ₩8.77 Billion ≈ $5.94 Million |
₩139.01 Billion ≈ $94.20 Million |
-14.48pp |
| 2020-12-31 | 20.79% | ₩23.82 Billion ≈ $16.14 Million |
₩114.57 Billion ≈ $77.64 Million |
-30.09pp |
| 2019-12-31 | 50.88% | ₩54.30 Billion ≈ $36.80 Million |
₩106.72 Billion ≈ $72.32 Million |
+41.93pp |
| 2018-12-31 | 8.96% | ₩3.49 Billion ≈ $2.37 Million |
₩38.97 Billion ≈ $26.41 Million |
+8.42pp |
| 2017-12-31 | 0.54% | ₩177.53 Million ≈ $120.31K |
₩32.86 Billion ≈ $22.27 Million |
-1.08pp |
| 2016-12-31 | 1.62% | ₩458.03 Million ≈ $310.40K |
₩28.30 Billion ≈ $19.18 Million |
-- |
About GREEN CROSS WellBeing Corporation
GREEN CROSS WellBeing Corporation provides personalized nutrition injections in South Korea. The company offers health supplements and food; prescription drugs; and aesthetics, as well as nutritional injections, including vitamins and antioxidants. GREEN CROSS WellBeing Corporation was founded in 2004 and is headquartered in Seoul, South Korea.